<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/42254/granules-india-ltd/rss" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Stock Rating update, March 15, 2024</title>
			<link>https://www.valueresearchonline.com/stories/54628/stock-rating-update-march-15-2024/</link>
			<pubDate>Tue, 19 Mar 2024 16:41:59 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/54628_stock-rating-update__w320__h240__.jpg&quot; alt=&quot;Stock Rating update, March 15, 2024&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Actionable insight based on valuation without losing sight of the fundamentals</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/54628/stock-rating-update-march-15-2024/</guid>
		</item>
		<item>
			<title>Why is this paracetamol maker bleeding?</title>
			<link>https://www.valueresearchonline.com/stories/54401/why-is-this-paracetamol-maker-bleeding/</link>
			<pubDate>Tue, 05 Mar 2024 16:48:44 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/54401_why-is-granules-india-bleeding__w320__h240__.jpg&quot; alt=&quot;Granules India&#039;s struggle: Plunging profits and recovery plan&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Discover why Granules India, a leading paracetamol API manufacturer, faces a 22% profit drop and operational challenges, yet plans for a strong comeback.</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/54401/why-is-this-paracetamol-maker-bleeding/</guid>
		</item>
		<item>
			<title>Companies falling short of cash</title>
			<link>https://www.valueresearchonline.com/stories/46895/companies-falling-short-of-cash/</link>
			<pubDate>Thu, 16 May 2019 08:58:17 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/46895_falling-short__w320__h240__.jpg&quot; alt=&quot;Companies falling short of cash&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Rising short-term borrowings coupled with rising receivables mean that a company is not getting cash as fast as it is spending it</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/46895/companies-falling-short-of-cash/</guid>
		</item>
		<item>
			<title>Decoding capital expenditure</title>
			<link>https://www.valueresearchonline.com/stories/46225/decoding-capital-expenditure/</link>
			<pubDate>Thu, 08 Nov 2018 08:00:00 +0530</pubDate>
			<category>Data for Thought</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/46225_in-expansion-mode__w320__h240__.jpg&quot; alt=&quot;Decoding capital expenditure&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Here&#039;s why rising capex can be a good indicator of a company&#039;s growth. Also, find the names of some companies whose capex has risen consistently</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/46225/decoding-capital-expenditure/</guid>
		</item>
		<item>
			<title>The pledge tracker</title>
			<link>https://www.valueresearchonline.com/stories/45837/the-pledge-tracker/</link>
			<pubDate>Thu, 05 Jul 2018</pubDate>
			<category>Data for Thought</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/45837_pledge1__w320__h240__.jpg&quot; alt=&quot;The pledge tracker&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Here&#039;s a list of companies in which promoter pledging has shown a marked rise or fall between December 2017 and March 2018</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/45837/the-pledge-tracker/</guid>
		</item>
		<item>
			<title>Eight For 2007</title>
			<link>https://www.valueresearchonline.com/stories/9661/eight-for-2007/</link>
			<pubDate>Thu, 01 Feb 2007</pubDate>
			<category>Special Report</category>
			<description>Even if you are the perennially optimistic investor who does not believe that the Indian growth story is anywhere near its conclusion, you have to admit that the bulls are running out of steam.></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/9661/eight-for-2007/</guid>
		</item>
		<item>
			<title>In Focus: Right Prescription</title>
			<link>https://www.valueresearchonline.com/stories/9780/in-focus-right-prescription/</link>
			<pubDate>Fri, 01 Sep 2006 16:47:00 +0530</pubDate>
			<category>Stock Focus</category>
			<description>Granules’ expansion plans is putting it on a global pedestal></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/9780/in-focus-right-prescription/</guid>
		</item>
    </channel>
</rss>
